Physician Wealth Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Physician Wealth Advisors’s Portfolio ARQT Stock Details ARQT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21K	Hold	46	–	–	﹤0.01%	1749
2026 Q1	$1.08K	Hold	46	–	–	﹤0.01%	1635
2025 Q4	$1.34K	Hold	46	–	–	﹤0.01%	1472
2025 Q3	$868	Hold	46	–	–	﹤0.01%	1658
2025 Q2	$645	Buy	+46	New	+$645	﹤0.01%	1638

Other funds holding ARQT

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

JAFL

Jay A. Fishman Ltd Troy, Michigan $1.26B AUM 31.39% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Physician Wealth Advisors's ARQT Position: Q2 2026 in Review

Physician Wealth Advisors held its Arcutis Biotherapeutics (ARQT) position steady in Q2 2026 at 46 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

Physician Wealth Advisors first reported a position in ARQT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.34K in Q4 2025. 53 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

Physician Wealth Advisors held 46 shares of Arcutis Biotherapeutics worth $1.21K as of Q2 2026.
Physician Wealth Advisors left its Arcutis Biotherapeutics share count unchanged in Q2 2026.
Arcutis Biotherapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1749 holding.
Physician Wealth Advisors first reported a position in Arcutis Biotherapeutics in Q2 2025 and has held it in 5 quarters since.
Physician Wealth Advisors's Arcutis Biotherapeutics position peaked at $1.34K in Q4 2025.
53 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.